These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 23816768

  • 1. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G, Khera M, Bhattacharya RK, Kushner H, Miner MM.
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [Abstract] [Full Text] [Related]

  • 2. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G.
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [Abstract] [Full Text] [Related]

  • 3. 12-month observation of testosterone replacement effectiveness in a general population of men.
    Miner MM, Bhattacharya RK, Blick G, Kushner H, Khera M.
    Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767
    [Abstract] [Full Text] [Related]

  • 4. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS).
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    J Sex Med; 2011 Nov; 8(11):3204-13. PubMed ID: 21834870
    [Abstract] [Full Text] [Related]

  • 5. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS).
    Blick G, Khera M, Bhattacharya RK, Nguyen D, Kushner H, Miner MM.
    Pain Med; 2012 May; 13(5):688-98. PubMed ID: 22536837
    [Abstract] [Full Text] [Related]

  • 6. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS).
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    Aging Male; 2012 Mar; 15(1):14-21. PubMed ID: 22092151
    [Abstract] [Full Text] [Related]

  • 7. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
    Bhattacharya RK, Khera M, Blick G, Kushner H, Miner MM.
    Clin Interv Aging; 2012 Mar; 7():321-30. PubMed ID: 22956867
    [Abstract] [Full Text] [Related]

  • 8. Testim 1% testosterone gel for the treatment of male hypogonadism.
    Bouloux P.
    Clin Ther; 2005 Mar; 27(3):286-98. PubMed ID: 15878382
    [Abstract] [Full Text] [Related]

  • 9. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM, Simhan J, Carson CC.
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [Abstract] [Full Text] [Related]

  • 10. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
    [Abstract] [Full Text] [Related]

  • 11. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M, Canty DJ, Shabsigh R.
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [Abstract] [Full Text] [Related]

  • 12. Review of Testim gel.
    McNicholas T, Ong T.
    Expert Opin Pharmacother; 2006 Mar; 7(4):477-84. PubMed ID: 16503819
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men.
    Grober ED, Khera M, Soni SD, Espinoza MG, Lipshultz LI.
    Int J Impot Res; 2008 Mar; 20(2):213-7. PubMed ID: 17898800
    [Abstract] [Full Text] [Related]

  • 14. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
    Wu XY, Mao JF, Lu SY, Zhang Q, Shi YF.
    Chin Med J (Engl); 2009 Dec 05; 122(23):2846-50. PubMed ID: 20092788
    [Abstract] [Full Text] [Related]

  • 15. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G, Cole N, Bhartia M, Kennedy D, Raju J, Wilkinson P, Saghir A, Blast Study Group.
    Int J Clin Pract; 2014 Feb 05; 68(2):203-15. PubMed ID: 24355040
    [Abstract] [Full Text] [Related]

  • 16. Registry of Hypogonadism in Men (RHYME): design of a multi-national longitudinal, observational registry of exogenous testosterone use in hypogonadal men.
    Rosen RC, Wu FC, Behre HM, Roehrborn CG, Schröder FH, Siami FS, Martha JF, Finn JD, Araujo AB.
    Aging Male; 2013 Mar 05; 16(1):1-7. PubMed ID: 23373674
    [Abstract] [Full Text] [Related]

  • 17. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME).
    Rosen RC, Wu F, Behre HM, Porst H, Meuleman EJH, Maggi M, Romero-Otero J, Martinez-Salamanca JI, Jones TH, Debruyne FMJ, Kurth KH, Hackett GI, Quinton R, Stroberg P, Reisman Y, Pescatori ES, Morales A, Bassas L, Cruz N, Cunningham GR, Wheaton OA, RHYME Investigators.
    J Sex Med; 2017 Sep 05; 14(9):1104-1115. PubMed ID: 28781213
    [Abstract] [Full Text] [Related]

  • 18. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
    Rhoden EL, Morgentaler A.
    Int J Impot Res; 2006 Sep 05; 18(2):201-5. PubMed ID: 16177827
    [Abstract] [Full Text] [Related]

  • 19. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS, Fernandez HH, Rodriguez RL, Romrell J, Suelter M, Munson S, Louis ED, Mulligan T, Foster PS, Shenal BV, Armaghani SJ, Jacobson C, Wu S, Crucian G.
    Arch Neurol; 2006 May 05; 63(5):729-35. PubMed ID: 16682542
    [Abstract] [Full Text] [Related]

  • 20. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF, Reid M, Madden W, Burnett AL.
    Andrology; 2013 Jul 05; 1(4):576-82. PubMed ID: 23606509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.